International Patent: ANTIBODIES THAT BIND INTERLEUKIN 4 RECEPTOR ALPHA IN COMBINATION WITH HYALURONIDASE OR A VARIANT THEREOF

GENEVA, June 26 -- APOGEE THERAPEUTICS, INC. filed a patent application (US2025/051425) for “ANTIBODIES THAT BIND INTERLEUKIN 4 RECEPTOR ALPHA IN COMBINATION WITH HYALURONIDASE OR A VARIANT THEREOF”. With publication no. WO/2026/085417, here are the other details related to the patent application:

Kind: Later publication of international search report [A3]

IPC: A61K 39/395

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....